AOI Medical, Inc. Director's dealings
February 13 2009 - 1:00AM
UK Regulatory
TIDMAOI
RNS Number : 2632N
AOI Medical, Inc.
13 February 2009
Press Information
AOI Medical, Inc.
Directors' dealings
London, UK, 13 February 2009 - AOI Medical, Inc. (the "Company" or "AOI") (AIM:
AOI) announces that it was notified on 11 February 2009 that certain of its
directors have dealt in shares of common stock of US$0.0001 par value of the
Company ("Common Shares") in a number of off-market trades during the period
from June 2008 to December 2008 which had previously not been notified to the
Company. Details of these dealings in Common Shares are set out below.
John Feltman, the Non-executive Chairman of the Company, made the following
disposals in Common Shares during the period from June 2008 to December 2008:
+-------------------------+-------------------------+-------------------------+-------------------------+
| Date | Number of Common Shares | Price per Common Share | Total Purchase Price |
| | | (US$) | (US$) |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 23 June 2008 | 1,486 | 2.69 | 4,000 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 1 July 2008 | 3,000 | 4.06 | 12,180 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 10 July 2008 | 900 | 4.04 | 3,636 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 30 July 2008 | 13,000 | 3.85 | 50,050 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 25 August 2008 | 26,000 | 3.85 | 100,100 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 27 August 2008 | 4,213 | 3.56 | 15,000 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 31 October 2008 | 6,807 | 2.94 | 20,000 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 30 November 2008 | 7,896 | 2.53 | 20,000 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 24 December 2008 | 2,000* | GBP1.81 | GBP3,612.50 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 24 December 2008 | 16,000 | 2.52 | 40,320 |
+-------------------------+-------------------------+-------------------------+-------------------------+
| 29 December 2008 | 20,000 | 2.52 | 50,400 |
+-------------------------+-------------------------+-------------------------+-------------------------+
* Common Shares sold to Paul Garvey, Non-executive Director of the Company
In addition, on 1 November 2008 John Feltman disposed of a total of 3,000 Common
Shares by way of gift, without receipt of any consideration. Following the above
disposals, John Feltman's resultant shareholding is 3,575,536 Common Shares,
equivalent to 42.38 per cent. of the Company's issued share capital.
Paul Garvey, a Non-executive Director of the Company, purchased 2,000 Common
Shares from John Feltman on 24 December 2008 for a total purchase price of
GBP3,612.50, equivalent to a price of GBP1.81 per Common Share. Paul Garvey's
resultant shareholding is 2,000 Common Shares, equivalent to 0.02 per cent. of
the Company's issued share capital.
Enquiries:
+-----------------------------------------------------------------+----------------------------------+
| AOI Medical, Inc. | Tel: +1 407 770 1800 |
+-----------------------------------------------------------------+----------------------------------+
| William J. Christy, CEO | |
+-----------------------------------------------------------------+----------------------------------+
| Angela Johnston, CFO | |
+-----------------------------------------------------------------+----------------------------------+
| | |
+-----------------------------------------------------------------+----------------------------------+
| Numis Securities Limited | Tel: +44 (0) 20 7260 1000 |
+-----------------------------------------------------------------+----------------------------------+
| Nominated Adviser: Michael Meade / Brent Nabbs | |
+-----------------------------------------------------------------+----------------------------------+
| Corporate Broking: David Poutney | |
+-----------------------------------------------------------------+----------------------------------+
| | |
+-----------------------------------------------------------------+----------------------------------+
| The Investor Relations Group | |
+-----------------------------------------------------------------+----------------------------------+
| Erika Moran/Tom Caden | Tel: +1 212 825 3210 |
+-----------------------------------------------------------------+----------------------------------+
| Public Relations: Susan Morgenbesser | |
+-----------------------------------------------------------------+----------------------------------+
Background to AOI Medical, Inc.
AOI is a medical device company focusing on the development and
commercialisation of innovative orthopaedic medical devices for the spine and
trauma markets. It is progressing the development of three separate technology
platforms: Ascendx(TM) VCF Reduction System, BAMF
Trauma and Cervical Plate. Further information can be found at www.aoimedical.n
t
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSIFFVFFIIFLIA
Aoi (Regs) (LSE:AOI)
Historical Stock Chart
From Feb 2025 to Mar 2025
Aoi (Regs) (LSE:AOI)
Historical Stock Chart
From Mar 2024 to Mar 2025
Real-Time news about Aoi (Regs) (London Stock Exchange): 0 recent articles
More AOI Medical, Inc. News Articles
